Trial Comparing Two Carboplatin Doses in Groups C and D Intraocular Retinoblastoma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.

Verified February 2012 by Rachna Meel, All India Institute of Medical Sciences, New Delhi.
Recruitment status was: Active, not recruiting

Sponsor:

ClinicalTrials.gov Identifier:

NCT00889018

First Posted: April 28, 2009

Last Update Posted: February 9, 2012

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Collaborator:

Council of Scientific and Industrial Research, India

Information provided by (Responsible Party):

Rachna Meel, All India Institute of Medical Sciences, New Delhi

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2012
Estimated Primary Completion Date:	April 2012 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Meel R, Bakhshi S, Pushker N, Vishnubhatla S. Randomized, controlled trial in groups C and D retinoblastoma. Ophthalmology. 2015 Feb;122(2):433-5. doi: 10.1016/j.ophtha.2014.09.013. Epub 2014 Oct 22.

To Top